Radiolabeling and in vivo evaluation of lanmodulin with biomedically relevant lanthanide isotopes

Kirsten E. Martin, Joseph A. Mattocks, Dariusz Śmiłowicz, Eduardo Aluicio-Sarduy, Jennifer N. Whetter, Jonathan W. Engle, Joseph A. Cotruvo, Eszter Boros

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Abstract

Short-lived, radioactive lanthanides comprise an emerging class of radioisotopes attractive for biomedical imaging and therapy applications. To deliver such isotopes to target tissues, they must be appended to entities that target antigens overexpressed on the target cell's surface. However, the thermally sensitive nature of biomolecule-derived targeting vectors requires the incorporation of these isotopes without the use of denaturing temperatures or extreme pH conditions; chelating systems that can capture large radioisotopes under mild conditions are therefore highly desirable. Herein, we demonstrate the successful radiolabeling of the lanthanide-binding protein, lanmodulin (LanM), with medicinally relevant radioisotopes: 177Lu, 132/135La and 89Zr. Radiolabeling of the endogenous metal-binding sites of LanM, as well exogenous labeling of a protein-appended chelator, was successfully conducted at 25 °C and pH 7 with radiochemical yields ranging from 20-82%. The corresponding radiolabeled constructs possess good formulation stability in pH 7 MOPS buffer over 24 hours (>98%) in the presence of 2 equivalents of natLa carrier. In vivo experiments with [177Lu]-LanM, [132/135La]-LanM, and a prostate cancer targeting-vector linked conjugate, [132/135La]-LanM-PSMA, reveal that endogenously labeled constructs produce bone uptake in vivo. Exogenous, chelator-tag mediated radiolabeling to produce [89Zr]-DFO-LanM enables further study of the protein's in vivo behavior, demonstrating low bone and liver uptake, and renal clearance of the protein itself. While these results indicate that additional stabilization of LanM is required, this study establishes precedence for the radiochemical labeling of LanM with medically relevant lanthanide radioisotopes.

Original languageEnglish (US)
Pages (from-to)414-421
Number of pages8
JournalRSC Chemical Biology
Volume4
Issue number6
DOIs
StatePublished - Apr 13 2023

All Science Journal Classification (ASJC) codes

  • Chemistry (miscellaneous)
  • Biochemistry
  • Molecular Biology
  • Biochemistry, Genetics and Molecular Biology (miscellaneous)

Fingerprint

Dive into the research topics of 'Radiolabeling and in vivo evaluation of lanmodulin with biomedically relevant lanthanide isotopes'. Together they form a unique fingerprint.

Cite this